Results 301 to 310 of about 655,937 (417)

Hijacking the BAF complex: the mechanistic interplay of ARID1A and EWS::FLI1 in Ewing sarcoma

Molecular Oncology, Volume 19, Issue 4, Page 961-964, April 2025.
Ewing sarcoma is driven by the EWS::FLI1 fusion protein, which disrupts gene expression by hijacking the BAF complex via ARID1A. ARID1A's ability to form biomolecular condensates is crucial for tumor growth, making it a potential therapeutic target. However, targeting these transient condensates is challenging, requiring further research. Ewing sarcoma,
Erich J. Sohn, David S. Libich
wiley   +1 more source

Family-Related Motivation and Regret Intensity Among Family Liver Donors by Type of Family Relationship. [PDF]

Ann Transplant
Lee YS, Koh CK, Yi NJ.
europepmc   +1 more source

Preoperative autologous donation: what have we learned? [PDF]

, 1991
Arthur J. Silvergleid
openalex   +1 more source

Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis

Journal of Assisted Reproduction and Genetics, 2016
A. Blázquez, D. Garcia, Amelia Rodríguez, R. Vassena, F. Figueras, V. Vernaeve   +5 more
semanticscholar   +1 more source

Genomic landscape and preclinical models of angiosarcoma

Molecular Oncology, Volume 19, Issue 4, Page 965-983, April 2025.
Angiosarcomas are a rare and aggressive cancer with a poor prognosis for patients. The genomic landscape of angiosarcoma can be highly complex and heterogenous; however, recent studies have identified some common features especially within anatomic and molecular subgroups.
Annaleigh Benton, Bozhi Liu, Lauren E. Gartenhaus, Jason A. Hanna   +3 more
wiley   +1 more source

Alleviating the emotional burden on families during organ donation requests in neurologic patients declared with brain death: the role of timing and circumstances of death. [PDF]

Arch Public Health
Powla PP, Turaka D, Fakhri F.
europepmc   +1 more source

INTRVASCULAR COAGULATION AND KIDNEY DONATION

, 1986
Karel M.L. Leunissen
openalex   +1 more source

Targeting rapid TKI‐induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3/ITD acute myeloid leukemia

Molecular Oncology, Volume 19, Issue 5, Page 1386-1403, May 2025.
Adaptive ERK reactivation hinders FLT3 tyrosine kinase inhibitor (TKI) treatment in FLT3/ITD acute myeloid leukemia. Here, we report that FLT3 TKI treatment rapidly induces AXL expression and upregulation that is temporally associated with the adaptive ERK reactivation.
Tessa S. Seale, Li Li, J. Kyle Bruner, Melody Chou, Bao Nguyen, Jaesung Seo, Ruiqi Zhu, Mark J. Levis, Christine A. Pratilas, Donald Small   +9 more
wiley   +1 more source

Evolutionary dynamics of behavioral motivations for cooperation. [PDF]

Nat Commun
Su Q, Stewart AJ.
europepmc   +1 more source

Combined spatially resolved metabolomics and spatial transcriptomics reveal the mechanism of RACK1‐mediated fatty acid synthesis

Molecular Oncology, EarlyView.
The authors analyzed the spatial distributions of gene and metabolite profiles in cervical cancer through spatial transcriptomic and spatially resolved metabolomic techniques. Pivotal genes and metabolites within these cases were then identified and validated.
Lixiu Xu, Jinqiu Li, Junqi Ma, Ayshamgul Hasim   +3 more
wiley   +1 more source